Since 2012 we have helped biopharma companies, CROs, hospitals and governments see where clinical research happens, how health systems perform, and where to act.
Value of industry-sponsored clinical trials in Poland in 2019, supporting around 9,000 jobs.
Report for INFARMA and POLCRO, 2022
Lower population-adjusted access to trials of novel compounds in the Middle East and North Africa than in the US.
Misik et al., Applied Clinical Research, Clinical Trials & Regulatory Affairs, 2017
Arab countries benchmarked on trial participation against pharmaceutical consumption.
Mišík, Boleček, Brady, Research Ethics in the Arab Region, Springer 2017
LT Analytics, our online platform for self-service research.
LT Analytics brings standardised data on industry-sponsored clinical trials from many sources into one place, so you can run your own reports. Subscribe to the full suite or to a single module.
Global trending and geographic benchmarking
For pharma, CROs, medical institutions, regulators, patient groups, investors and media.
Planning new clinical trials
For pharma, CROs, medical institutions, regulators, investors and media.
Performance improvement and internal benchmarking
For CROs and sponsors running trials in several countries.
Advisory, research and reporting from the LongTaal Institute.
When you need interpretation as well as data, our advisory team combines LongTaal data with scientific and industry literature and its own expertise, and delivers reports, research papers and presentations.
For sponsors, CROs, industry associations and research institutions
For ministries, payers, hospitals and healthcare providers
Market data from LT Trend made us far more credible with new clients, because we could show detailed knowledge of the clinical landscape. Our feasibilities became faster and more accurate, on average 30% faster, and LT Perform now lets us assess our teams on productivity, delivery and customer satisfaction.
As a scientist and later a large CRO executive, I helped LongTaal design the products I was looking for but could not find on the market. Feedback from customers is a constant loop that keeps improving them.
Reports, publications and company news.
Commissioned by INFARMA and POLCRO and powered by LT Analytics. Poland ranked 11th worldwide by trial market share in 2019. The report models a growth and a correction scenario to 2030, a difference of about USD 6.3 billion. Available in English and Polish.
Request the reportThe region has over 900 identified common genetic disorders, modern facilities and internationally aligned regulation, yet the ten largest rare-disease sponsors have run only about 70 studies there since 2008. Includes three country case studies.
Request the reportMisik, Brady, Boleček and Klech analyse Phase II and III trial sites from 2009 to 2014. North America and Western Europe kept over 70% of trial share, Central and Eastern Europe held steady, and MENA stayed below 0.2%.
LongTaal Institute analytics for a chapter in Springer’s Research Ethics in the Arab Region, comparing trial participation with pharmaceutical consumption in 12 Arab countries.
Read the chapter on SpringerSeminars hosted by Roche Saudi Arabia with Dr Vladimir Misik. Trials could give around 5,000 Saudi patients a year access to new therapies, create over 2,000 high-end jobs and bring about USD 160 million in annual R&D investment.
Belgium, the USA or Hungary: which gives patients the most access to trials per million population? The answer is Hungary, reflecting the long-standing strength of Central and Eastern Europe in clinical research.
New partnerships with SanaClis, PPH plus and nRollmed extend our services across trial operations, consultancy and patient recruitment.
Shortlisted from about 200 start-ups in the Software category of the Vodafone Idea of the Year awards.
With SanaClis, we demonstrated LT Analytics to sponsors and CROs at SCOPE 2017 in Miami.
A real-life example of LongTaal analytics, presented at the Clinical Research in Turkey, Middle East & North Africa Leaders Forum in Dubai.
Data on over 55,000 industry-sponsored studies in more than 150 countries, organised into 24 therapeutic areas and about 1,700 sub-areas, with trends at country, regional and global level.
SanaClis, a full-service CRO in Central and Eastern Europe, chose LongTaal as its clinical trial analytics partner in 2015.
Founded in 2012 in Bratislava.
LongTaal was founded by a small team of experts in biomedical research and development. We give policy-makers, medical institutions, biopharmaceutical companies and contract research organisations easy access to information about industry-sponsored clinical trials and the health systems they run in.
Our clients use these insights to plan trials faster and more accurately, assess market potential and market share, focus business development, estimate clinical research revenue and study demographic trends. As they find new uses for the data, we extend our services to match.
Tell us what you need to know and we will suggest how to get there.